MedTrace Logo

Monitoring Glucose Levels in Patients With Myocardial Infarction

NCT03107806 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2019-08-15

No results posted yet for this study

Summary

To evaluate the OptiScanner® for continuous glucose monitoring as a tool to optimize glucose levels in patients hospitalized for acute coronary syndromes

Conditions

Interventions

DEVICE

OptiScanner®

1. Glucose monitoring by OptiScanner® for 48 h 2. Glucose lowering intervention (insulin) guided by OptiScanner®

Sponsors & Collaborators

  • Karolinska Institutet

    collaborator OTHER

  • Swedish Heart Lung Foundation

    collaborator OTHER

  • Lars Ryden

    lead OTHER

Principal Investigators

  • Camilla Hage, PhD · Karolinska Institutet

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2018-01-31
Completion
2018-01-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03107806 on ClinicalTrials.gov